https://idataresearch.com/wp-content/themes/lambda-child-theme/images/footer-logo.png
https://idataresearch.com/wp-content/themes/lambda-child-theme/images/idata-white-logo.png

Report Library

Showing all 6 results

Ulcerative Colitis Drug Market Analysis | Europe | 2018-2024 | MedCore

This market report includes a detailed analysis of the drugs used to treat ulcerative colitis across the globe (12 countries), including Entyvio, Humira, Remicade, and Simponi. The ulcerative colitis drug market is largely driven by the expiry of patents and the entry of biosimilars which present strong competition for the biologics listed above.

more...

Psoriasis Drug Market Analysis | Europe | 2018-2024 | MedCore

This market report includes a detailed analysis of the drugs used to treat psoriasis across the globe (12 countries), including Humira, Enbrel, Remicade, and Stelera. The psoriasis drug market is largely driven by the expiry of patents and the entry of biosimilars which present strong competition for the biologics listed above.

more...

Rheumatoid Arthritis Drug Market Analysis | Europe | 2018-2024 | MedCore

This market report includes a detailed analysis of the drugs used to treat rheumatoid arthritis across the globe (12 countries), including Orencia, Humira, Cimzia, Enbrel, Simponi, Remicade, Rituxan, Actemra, and Xeljanz. The rheumatoid arthritis drug market is largely driven by the expiry of patents and the entry of biosimilars which present strong competition for the biologics listed above.

more...

Ankylosing Spondylitis Drug Market Analysis | Europe | 2018-2024 | MedCore

This market report includes a detailed analysis of the drugs used to treat ankylosing spondylitis across the globe (12 countries), including Humira, Cimzia, Enbrel, Simponi, and Remicade. The ankylosing spondylitis drug market is largely driven by the expiry of patents and the entry of biosimilars which present strong competition for the biologics listed above.

more...

Crohn’s Disease Drug Market Analysis | Europe | 2018-2024 | MedCore

This market report includes a detailed analysis of the drugs used to treat Crohn's disease across the globe (12 countries), including Humira, Cimzia, Remicade, Stelara, Entyvio, and Tysabri. The Crohn's disease drug market is largely driven by the expiry of patents and the entry of biosimilars which present strong competition for the biologics listed above.

more...

Labs, Structural Heart and Coronary Stents Product Portfolio and Pipeline | Global | 2017-2023 | Survey

iData provides one of the most comprehensive and efficient market research survey services in the world using a 5-step methodology. Whether it is to gauge end-user behavior regarding new or existing products, competitor’s products, purchasing habits, marketing penetration/effectiveness rates, ad testing or obtaining statistically significant quantitative data on specific products and services, iData’s survey team is equipped and ready to engage.

more...